Effect of rhTNF-α injection into rat sciatic nerve

Journal of Neuroimmunology

Volumn 94, Issue 1-2, 1999, Pages 88-94

  Uncini, Antonino ^a   Di Muzio, Antonio ^a   Di Guglielmo, Giovanni ^a   De Angelis, Maria Vittoria ^a   De Luca, Giovanna ^a   Lugaresi, Alessandra ^a   Gambi, Domenico ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Blood nerve barrier; Electrophysiological effects; Intraneural injection; Nerve edema; Pathology; RhTNF ct

Indexed keywords

RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; DEMYELINATING DISEASE; EDEMA; MUSCLE ACTION POTENTIAL; NERVE COMPRESSION; NERVE FIBER DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ACTION POTENTIALS; ANIMALS; BIOLOGICAL TRANSPORT; DEMYELINATING DISEASES; EDEMA; ELECTROPHYSIOLOGY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; MALE; MICROINJECTIONS; NERVE DEGENERATION; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TIBIAL NERVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033081190     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00229-X     Document Type: Article

References (32)

1. Brosnan C.F., Litwak M.S., Schroeder C.E., Selmaj K., Raine C.S., Arezzo J.C. Preliminary studies of cytokine-induced effects on the visual pathways in the rabbit. J. Neuroimmunol. 25:1989;227-239.
2. Butt A.M., Jenkins H.G. Morphological changes in oligodendrocytes in the intact mouse optic nerve following intravitreal injection of tumor necrosis factor. J. Neuroimmunol. 51:1994;27-33.
3. Frei K., Eugster H.P., Bopst M., Constantinescu C.S., Lavi E., Fontana A. Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1997;2177-2182.
4. Hartung H.P. Immune mediated demyelination. Ann. Neurol. 33:1993;563-567.
5. Hartung H.P., Jung S., Stoll G., Zielasek J., Schmidt B., Archelos J.J., Toyka K.V. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40:1992;197-210.
6. Jenkins H.G., Ikeda H. Tumor necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve. J. Neurol. Sci. 108:1992;99-104.
7. Kagan B.L., Baldwin R.L., Munoz D., Wisnieski B.J. Formation of ion-permeable channels by tumor necrosis factor-α Science. 255:1992;1427-1930.
8. Mithen F.A., Colburn S., Birchen R. Human alpha tumor necrosis factor does not damage cultures containing rat Schwann cells and sensory neurons. Neurosci. Res. 9:1990;59-63.
9. Olsson Y. Studies on vascular permeability in peripheral nerves: IV. Distribution of intravenously injected protein tracers in the peripheral nervous system of various species. Acta Neuropathol. 17:1971;114-126.
10. Olsson, Y., 1984. Vascular permeability in the peripheral nervous system. In: Dyck, P.J., Thomas, P.K., Lambert, E.H., Bunge, R. (Eds.). Peripheral Neuropathy. Saunders, Philadelphia, pp. 579-597.
11. Porrini A.M., Reder A.T. IFNb and PGE1 affect monokine secretion: relevance to monocyte activation in multiple sclerosis. Cell Immunol. 157:1994;428-438.
12. Redford E.J., Hall S.M., Smith K.J. Vascular changes and demyelination induced by the intraneural injection of tumor necrosis factor. Brain. 118:1995;869-878.
13. Said G., Hontebeyre-Joskowicz M. Nerve lesions induced by macrophage activation. Res. Immunol. 143:1992;589-599.
14. Selmaj K.W., Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:1988;339-346.
15. Selmaj K., Farooq M., Norton W.T., Raine C.S. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J. Immunol. 144:1990;129-135.
16. Selmaj K., Raine C.S., Cannella B., Brosnan C.F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87:1991;949-954.
17. Selmaj K., Raine C.S., Cross A.H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30:1991;694-700.
18. Selmaj K.W., Papierz W., Glabinski A., Kohno T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56:1995;135-141.
19. Sharief M.K., Hentges R. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325:1991;467-472.
20. Sharief M.K., Thompson E.J. In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis. J. Neuroimmunol. 38:1992;27-34.
21. Sharief M.K., McLean B., Thompson E.J. Elevated serum levels of tumor necrosis factor-α in Guillain-Barré syndrome. Ann. Neurol. 33:1993;591-596.
22. Sharief M.K., Ingram D.A., Swash M. Circulating tumor ecrosis factor-α correlates with electrodiagnostic abnormalities in Guillain-Barré syndrome. Ann. Neurol. 42:1997;68-73.
23. Simmons R.D., Willenborg D.O. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 100:1990;37-42.
24. Soliven B., Szuchet S., Nelson D.J. Tumor necrosis factor inhibits K+ current expression in cultured oligodendrocytes. J. Membrane Biol. 124:1991;127-137.
25. Spies J.M., Westland K.W., Bonner J.G., Pollard J.D. Intraneural activated T cells cause focal breakdown of the blood-nerve barrier. Brain. 118:1995;857-868.
26. Stoll G., Jung S., Jander S., van der Meide P., Hartung H.P. Tumor necrosis factor-α in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J. Neuroimmunol. 45:1993;175-182.
27. Tsukamoto T., Ishikawa M., Yamamoto T. Suppressive effects of TNF-α on myelin formation in vitro. Acta Neurol. Scand. 91:1995;71-75.
28. Uncini A., England J.D., Rhee E.K., Duckett S.W., Sumner A.J. Tellurium-induced demyelination: an electrophysiological and morphological study. Muscle Nerve. 11:1988;871-879.
29. Uncini A., Santoro M., Corbo M., Lugaresi A., Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve. 16:1993;610-615.
30. Vassalli P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:1992;411-452.
31. Wagner R., Myers R.R. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience. 73:1996;625-629.
32. Wright J.L., Merchant R.E. Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-α in the rat. Acta Neuropathol. 85:1992;93-100.